AMEX · Medical - Instruments & Supplies

MLSS (MLSS) Stock

$0.40 +3.13% AMEX: MLSS Healthcare

Valuation

MetricValue
Price$0.40
Market Cap$35.59M
P/E Ratio-10.04
P/B Ratio12.55
P/S Ratio3.48
EPS (TTM)$-0.04
52-Week High$0.87
52-Week Low$0.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-135.38%
ROA-33.19%
ROCE-200.00%
Gross Margin70.37%
Operating Margin-50.84%
Net Margin-51.30%
Debt/Equity0.43
Current Ratio1.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$9.0M$10.0M$9.0M$9.0M
Operating Profit$-7.0M$-9.0M$-7.0M$-7.0M$-6.0M
Net Profit$-7.0M$-9.0M$-7.0M$-5.0M$-6.0M
EPS$-0.10$-0.12$-0.10$-0.06$-0.07
Op Margin-71.6%-100.2%-72.3%-78.3%-63.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.0M$14.0M$11.0M$10.0M$8.0M
Total Liabilities$4.0M$4.0M$3.0M$4.0M$5.0M
Cash$15.0M$9.0M$3.0M$3.0M$1.0M
Borrowings$1.0M$0$0$0$1.0M

Latest News

Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026 GlobeNewswire · Jul 15, 2026 Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY GlobeNewswire · Jul 1, 2026 Milestone Scientific Strengthens Board to Support Next Phase of Growth GlobeNewswire · Jun 25, 2026 Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures GlobeNewswire · May 27, 2026 Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ... GuruFocus.com · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-6.0M$-5.0M$-3.0M$-3.0M
Investing Cash Flow$0$0$-3.0M$3.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$-6.0M$-6.0M$0$-2.0M
Free Cash Flow$-4.0M$-6.0M$-5.0M$-3.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA-6.88
FCF Yield-5.89%
Quick Ratio0.79
Interest Coverage
Return 1Y-35.30%
Return 3Y-63.35%
Return 5Y-75.50%

Ownership

Insiders Held16.06%
Institutions Held5.11%
Institutions Float Held6.09%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC1,986,6482026-03-31
Geode Capital Management, LLC616,6452026-03-31
Vanguard Fiduciary Trust Co321,5832026-03-31
Citadel Advisors Llc167,1352026-03-31
State Street Corporation139,8852026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APUS $5.15 +4.67% -7.51 $7.77M 0.00%
HBIO $6.10 +0.16% -0.42 $27.51M 0.00%
IGC $0.26 +2.68% $25.68M 0.00%
MIRA $0.91 +3.15% -0.73 $38.22M 0.00%
MYO $1.01 +4.12% -5.45 $39.03M 0.00%

About MLSS

MLSS is led by CEO Eric C. Hines, publicly traded since 1995.

MLSS stock trades at $0.40 with a market capitalization of $35.59M. The stock is valued at a price-to-earnings (P/E) ratio of -10.04, price-to-book of 12.55, price-to-sales of 3.48. Over the past 52 weeks the stock has ranged between $0.22 and $0.87, and currently trades 54.0% below its 52-week high.

On profitability, MLSS generates a return on equity (ROE) of -135.38%, return on capital employed of -200.00%, an operating margin of -50.84%, a net profit margin of -51.30%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides